RO4917838 (Bitopertin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RO4917838 (Bitopertin), covering 2016-11-02 to 2016-11-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25305) [Phase 3]